Dyneval turns microscale motion into actionable insights
Dyneval Ltd was founded in 2020 by complex Fluid Physicists Dr Tiffany Wood and Dr Vincent Martinez. Their breakthrough in measuring microscopic motion led to the development of Dynescan, the first technology capable of precisely assessing semen motility over time, a unique platform technology which has gained global recognition.
At our Midlothian Science Zone Business Forum, on Tuesday 3rd February 2026, Dyneval co-founder Dr Tiffany Wood and Dr Joe Bradley, Dyneval Lumero Product Manager and expert in particle size distribution measurement introduced attendees to their latest technology, Lumero S1, a ground-breaking particle size analyser. This product signifies an expansion for Dyneval beyond their core semen analysis technology into industrial chemical characterisation.
Dr Tiffany Wood presenting in the Boardroom at Bush House during the Midlothian Science Zone Business Forum
Dyneval turns microscale motion into actionable insights. Starting in the livestock sector, its Dynescan semen analyser was the first tool to predict fertility potential by measuring semen quality over time—helping farmers boost conception rates, support sustainable agriculture, and reduce methane emissions.
Today, Dyneval has evolved into a platform technology that spans from bulls to biotech labs. Its expertise in particle motion powers solutions such as Lumero, giving researchers a clear view of nanoparticles and aggregates in suspensions and helping safeguard product quality across pharmaceuticals and biotechnology.
Lumero: Complete particle sizing to derisk development and improve yield
Dyneval has now launched Lumero S1 to expand its core measurement technology beyond the agricultural sector and into the pharmaceutical and life sciences markets. It is a dedicated brand for particle size analysis in complex industrial and medical applications.
New drug development is an expensive multi-stage, muti-billion pound process, with a high cost of failure, lengthy development timescales, expensive clinical trials and manufacturing and regulatory hurdles - all factors which must be overcome during new product development (NPD) and testing.
Screen presentation of Lumero capability
Lumero: Redefining particle size analysis
The significance of Lumero lies in its ability to provide true particle size distributions at almost any concentration without the need for sample dilution. The Lumero S1 can measure particle size distributions from nanometres to microns, at almost any concentration, by measuring their motion and interaction with light, and providing video evidence and traceability of any foreign particles within the test sample.
Lumero S1 provides a level of transparency that traditional "black box" measurement tools lack. In addition, this technology can help increase productivity and yield quality, identify problems earlier, and reduce waste by identifying and solving issues sooner, meaning a greater chance of successful trials.
Dyneval demonstrated to our audience the power of Lumero, and how objective, concentration-independent measurements transform pharmaceutical R&D, reduce risk, and reveal hidden issues before they become costly failures.
The advantages of this technology for drug development and the pharmaceutical sector are huge. Lumero S1 is time efficient, easy to use with video evidence and transferability, without the need for sample dilution. All of this, whilst retaining the learning from the agritech sector to make a device which is rugged, robust, and easy to use without specific expertise.
For more information about Dyneval, their services or a demonstration, please visit their website or contact the team directly.
Presenters Dr Tiffany Wood and Dr Joe Bradley, and Forum attendee Suzy Purcell, Chief Operating Officer at Roslin Foundation
We would like to thank all contributors of to our Business Forums and to those who participated. These networking events encourage collaboration, overlap and discussion which is our aim to encourage engagement across the zone.
Save the date for our next Midlothian Science Zone Business Forum on 14th April 2026, with more details and registration available soon – please check our Events page for updates.
If you would like to be notified of future MSZ Business Forum Events or to present at one of our events, please contact Emma McCallum, Project Co-ordinator.